Iambic Therapeutics is a startup based in the United States, 3 tracked investors.
Based in the United States, Iambic Therapeutics is a startup founded in 2020. Brouky records 3 investors associated with the company.
Iambic Therapeutics uses AI-driven technologies combined with high-throughput experimentation to discover and develop optimized drug candidates, focusing on transforming undruggable targets and advancing first-in-class therapies for cancer.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.